Lunai Bioworks Inc. Capital Expenditures
Lunai Bioworks Inc. (LNAI) reported Capital Expenditures of $1.24 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-05-15
- Lunai Bioworks Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00.
- Lunai Bioworks Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-06-30 was $23.55K, a 283.52% increase year-over-year.
- Lunai Bioworks Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-03-31 was $5.29K.
- Lunai Bioworks Inc. payments to acquire property, plant, and equipment for the quarter ending 2023-06-30 was $6.14K.
- Lunai Bioworks Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $70.43K, a 136.55% increase from fiscal 2023.
- Lunai Bioworks Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $29.77K, a 477.46% increase from fiscal 2022.
- Lunai Bioworks Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $5.16K, a 89.45% decline from fiscal 2021.
- Lunai Bioworks Inc. payments to acquire property, plant, and equipment for fiscal 2021 was $48.89K, a 73.49% decline from fiscal 2020.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | $1.24K 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $1.24K 10-Q · filed 2026-02-17 | ||||
| 2024-06-30 | $23.55K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-09-29 | $28.85K derived: sum of 2 quarters · filed 2025-09-29 | $70.43K 10-K · filed 2025-09-29 | ||
| 2024-03-31 | $5.29K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2025-02-19 | $46.88K 10-Q/A · filed 2025-02-19 | |||
| 2023-12-31 | $41.58K 10-Q · filed 2024-02-14 | ||||
| 2023-06-30 | $6.14K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-02-19 | $6.14K derived: sum of 2 quarters · filed 2025-02-19 | $29.77K 10-K/A · filed 2025-02-19 | ||
| 2023-03-31 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2025-02-19 | $23.63K 10-Q/A · filed 2025-02-19 | |||
| 2022-12-31 | $23.63K 10-Q · filed 2024-02-14 | ||||
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-02 | $0.00 derived: sum of 2 quarters · filed 2023-10-02 | $0.00 derived: sum of 3 quarters · filed 2023-10-02 | $5.16K 10-K · filed 2023-10-02 | |
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-05-12 | $5.16K 10-Q · filed 2023-05-12 | $43.33K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-09 | $5.16K 10-Q · filed 2023-03-09 | $43.33K derived: sum of 3 quarters · filed 2023-03-09 | $43.33K derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-09-30 | $5.16K 10-Q · filed 2023-03-07 | $43.33K derived: sum of 2 quarters · filed 2023-03-07 | $43.33K derived: sum of 3 quarters · filed 2023-03-07 | $54.05K derived: sum of 4 quarters · filed 2023-03-07 | |
| 2021-06-30 | $38.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $38.17K derived: sum of 2 quarters · filed 2023-02-27 | $48.89K derived: sum of 3 quarters · filed 2023-02-27 | $48.89K 10-K · filed 2023-02-27 | |
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | $10.72K derived: sum of 2 quarters · filed 2022-05-13 | $10.72K 10-Q · filed 2022-05-13 | $21.17K derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $10.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $10.72K 10-Q · filed 2022-02-14 | $21.17K derived: sum of 3 quarters · filed 2022-02-14 | $62.86K derived: sum of 4 quarters · filed 2022-02-14 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $10.45K derived: sum of 2 quarters · filed 2021-11-15 | $52.14K derived: sum of 3 quarters · filed 2021-11-15 | $115.85K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $10.45K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-24 | $52.14K derived: sum of 2 quarters · filed 2021-09-24 | $115.85K derived: sum of 3 quarters · filed 2021-09-24 | $184.46K 10-K · filed 2021-09-24 | |
| 2020-03-31 | $41.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | $105.40K derived: sum of 2 quarters · filed 2021-05-17 | $174.01K 10-Q · filed 2021-05-17 | $157.51K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $63.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | $132.32K 10-Q · filed 2021-02-16 | $115.81K derived: sum of 3 quarters · filed 2021-02-16 | $208.45K derived: sum of 4 quarters · filed 2021-02-16 | |
| 2019-09-30 | $68.62K 10-Q · filed 2020-11-12 | $52.11K derived: sum of 2 quarters · filed 2020-11-12 | $144.74K derived: sum of 3 quarters · filed 2020-11-12 | $477.10K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | -$16.51K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-23 | $76.13K derived: sum of 2 quarters · filed 2020-09-23 | $408.48K derived: sum of 3 quarters · filed 2020-09-23 | $716.67K 10-K · filed 2020-09-23 | |
| 2019-03-31 | $92.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $424.99K derived: sum of 2 quarters · filed 2020-05-11 | $733.18K 10-Q · filed 2020-05-11 | $733.18K derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $332.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-10 | $640.54K 10-Q · filed 2020-02-10 | $640.54K derived: sum of 3 quarters · filed 2020-02-10 | ||
| 2018-09-30 | $308.19K 10-Q · filed 2019-11-13 | $308.19K derived: sum of 2 quarters · filed 2019-11-13 | |||
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-30 | $30.00K 10-K · filed 2019-09-30 | |||
| 2018-03-31 | $30.00K 10-Q · filed 2019-05-16 | ||||
| 2014-03-31 | $41.50K 10-Q · filed 2015-05-13 | -$41.50K 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |